Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.37)
# 4,009
Out of 4,732 analysts
22
Total ratings
26.67%
Success rate
-27.46%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $72 → $68 | $27.23 | +149.72% | 2 | Oct 21, 2024 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.21 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $3.53 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $3.18 | +1,377.99% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $49 → $33 | $0.36 | +8,998.43% | 2 | Mar 28, 2023 | |
| ZYXI Zynex | Maintains: Buy | $27 → $28 | $7.68 | +264.58% | 1 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.87 | +4,712.83% | 1 | Aug 4, 2022 | |
| ECOR electroCore | Initiates: Buy | $45 | $15.90 | +183.02% | 1 | Jul 27, 2021 | |
| HROW Harrow | Initiates: Buy | $14 | $33.85 | -57.90% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.47 | +376.19% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $8.41 | +518.31% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11,025 | $0.22 | +5,031,848.88% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $5.94 | +17.85% | 1 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $6.37 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $67.69 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Oct 21, 2024
Maintains: Neutral
Price Target: $72 → $68
Current: $27.23
Upside: +149.72%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.21
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.53
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $3.18
Upside: +1,377.99%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $49 → $33
Current: $0.36
Upside: +8,998.43%
Zynex
Mar 28, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $7.68
Upside: +264.58%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.87
Upside: +4,712.83%
electroCore
Jul 27, 2021
Initiates: Buy
Price Target: $45
Current: $15.90
Upside: +183.02%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $33.85
Upside: -57.90%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.47
Upside: +376.19%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $8.41
Upside: +518.31%
Jun 26, 2020
Initiates: Buy
Price Target: $11,025
Current: $0.22
Upside: +5,031,848.88%
Sep 25, 2017
Initiates: Buy
Price Target: $7
Current: $5.94
Upside: +17.85%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $6.37
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $67.69
Upside: -